Ariad (ARIA) Gets Crushed After Its Only Approved Treatment Is Put On Hold

Shares of Ariad Pharmaceuticals (ARIA) crashed more than 70% last week, after the company reported that its top drug candidate, the leukemia drug Iclusig, had been put on a temporary hold by the FDA. The company announced that a number of patients given the drug experienced blood clots and heart damage. Daily Chart Ariad stated that Read the full article... Read the rest of Ariad (ARIA) Gets Crushed After Its Only Approved Treatment Is Put On Hold at InvestorGuide.com .